Correspondence to letter to the editor on “Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study” by Young Eun Chon, Dong Yun Kim, Hong Jae Chon, Do Young Kim

Subjects: “…sorafenib…”
Get full text

Familial Clinical Heterogeneity of Medullary Thyroid Cancer with Germline RET S891A Protooncogene Mutation: 7-year Follow-up with Successful Sorafenib Treatment by Sirmen Kızılcan Çetin, Zeynep Şıklar, Elif Özsu, Ayşegül Ceran, Koray Ceyhan, Zehra Aycan, Ayça Kırmızı, Handan Dinçaslan, Emel Ünal, Merih Berberoğlu

Subjects: Get full text

A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System by Dongdong Zhang, Dongdong Zhang, Dongdong Zhang, Ying Cai, Ying Cai, Ying Cai, Yixin Sun, Peiji Zeng, Wei Wang, Wenhui Wang, Xiaohua Jiang, Yifan Lian, Yifan Lian, Yifan Lian

Subjects: “…Sorafenib…”
Get full text

Successful two-stage operation for esophageal necrosis due to proton beam therapy followed by sorafenib in a case of large hepatocellular carcinoma by Eiji Higaki, Masahide Fukaya, Kazushi Miyata, Ryosuke Kawai, Tetsuya Abe

Subjects: Get full text

Targeted regulation of autophagy using sorafenib-loaded biomineralization nanoenzyme for enhanced photodynamic therapy of hepatoma by Tianming Lu, Zixian Liu, Ruoning Qian, Yitian Zhou, Jun Li, Qiang Zhang, Hao Yang, Wenli Lu, Yanlin Xin, Zejuan Xie, Lesan Yan, Shanshan Wang, Ruogu Qi, Zhengguang Zhang

Subjects: Get full text

Approaches to conducting a physiologically relevant test (PRT) in the study of medicines containing substance IIc of the BCS subclass using sorafenib as an example by A. V. Suvorova, Yu. V. Medvedev, P. A. Losenkova, O. S. Kramarenko, E. A. Malashenko, A. M. Poluyanov, I. E. Shohin

Subjects: “…sorafenib…”
Get full text

HPLC-UV method development and validation for anticancer drug sorafenib and the co-prescribed drug dexamethasone: application to pharmacokinetic evaluation of sorafenib nanoformula... by Abdul Mateen, Abad Khan, Ismail Khan, Saifullah Khan Khalil, Lateef Ahmad, Muhammad Junaid, Saqib Jehan, Muhammad Sohail Anwar, Muhammad Faheem, Abdul Salam

Subjects: Get full text

Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab–bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospec... by Jaekyung Cheon, Shigeo Shimose, Hyung-Don Kim, Takashi Niizeki, Min-Hee Ryu, Tomotake Shirono, Baek-Yeol Ryoo, Hideki Iwamoto, Changhoon Yoo

Subjects: Get full text

Sorafenib-Induced Spiny Follicular Hyperkeratosis: A Case Report with Review of Literature by Chandana Shajil, Dharshini Sathishkumar, Deepthi Boddu, Ramesh Babu Telugu

Subjects: Get full text

Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States by Finn RS, Iyer R, Kalman RS, Parikh ND, Cabrera R, Babajanyan S, Kaseb AO

Subjects: Get full text

Tyrosine kinase inhibitors were well-tolerated among patients with different etiologies of advanced HCC with lower survival in non-viral patients by Eman M. F. Barakat, Mohamed Kohla, Hossam Dabees, Hend Ibrahim Shousha, Ehab F. Moustafa, Mohamed El-Kassas, Mona Shoukry Aziz, Eman Elkhateeb, Ashraf Omar Abdelaziz, Mohamed Omar Abdelmalek, Aly Azmy, Ahmed Tawheed, Walaa Mosaad Aboganob, Hossam Taha, Rania Lithy, Ahmed Radwan, Dalia Ghoraba, Hamdy Sayed, Anwar Nassief, Mostafa Elhelbawy, Mohamed Mahmoud nabeel, Mohamed A. Medhat, Safaa Ragab Askar, Eman Marwan, Eman Rewisha, Tamer Elbaz, Sayed Hassan Ahmed, Nevien Fouad elfouly, Nermeen Abdeen, Ahmed Hosni Abdelmaksoud, Asmaa A. Abdeltawab, Mostafa Abd Alfattah Shamkh, Ahmed Ramadan, Yasser Arafat Abdelrazek, Mohamed Bassam, Sayed Ahmed Sayed, Rasha Salah Hussein, Ammar Alrajhi, Allam Elsayed Allam, Omnia A. Seyam, Mohamed Said

Subjects: Get full text

A bioanalytical method development and validation of leniolisib by reverse phase high-performance liquid chromatography in rat plasma and its application in pharmacokinetic studies by Charumathi Salva, Rajitha Galla

Subjects: Get full text

Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine by E. B. Vasil’eva, A. V. Vazhenin, T. M. Geliashvili, N. V. Fadeeva, A. V. Garev, A. O. Guz’

Subjects: Get full text

FLT3: A narrative review by Nikhil M Kumar, Shrinidhi Nathany, Anusha Swaminathan, Chitresh Yadav, Akriti Kothari, Paritosh Garg, Neha Panda-Rastogi, Vikas Dua, Arun Danewa, Rahul Bhargava

Subjects: Get full text

Possible Clinical Effects of Ketoconazole on Sorafenib-induced Hand–Foot Skin Reaction and Cytoprotection Mechanisms of Antifungal Agents against Multikinase Inhibitor-induced Kera... by Rui Kato, Yayoi Kamata, Mitsutoshi Tominaga, Ryoma Kishi, Takahide Kaneko, Akira Tsujimura, Yasushi Suga, Kenji Takamori

Subjects: Get full text

Anti-hepatoma effect of taccalonolide A through suppression of sonic hedgehog pathway by Hui Tian, Zhenkun He

Subjects: Get full text

FLT3 and IDH1/2 Inhibitors for Acute Myeloid Leukemia: Focused Clinical Narrative Review of Forthcoming Drugs from an Indian Context by Suvir Singh, Kunal Jain, Jagdeep Singh, Nitish Garg, Akriti Arora

Subjects: Get full text

PGV-1 Causes Disarrangement of Spindle Microtubule Organization Resulting in Aberrant Mitosis in HLF and HuH6 Cells Associated with Altered MYCN Status by Nadzifa Nugraheni, Ummi Maryam Zulfin, Beni Lestari, Novia Permata Hapsari, Muthi Ikawati, Rohmad Yudi Utomo, Yusuke Suenaga, Yoshitaka Hippo, Edy Meiyanto

Subjects: Get full text

Decoding Drug Interactions: Character and Degree of Pharmacokinetic Interactions Between Telmisartan and Sorafenib or Donafenib in Rats by Li Y, Du W, Shan C, Yu Z, An J, Dong Z

Subjects: Get full text

Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients by Liu CW, Lin PT, Teng W, Chen WT, Su CW, Hsieh YC, Lin CC, Lin CY, Lin SM

Subjects: Get full text